Tag Archives: nuclear medicine

EIB’s €230 Million Loan Supports UZ Leuven’s Infrastructure Overhaul and Research Growth in Belgium

(IN BRIEF) UZ Leuven has secured a €230 million loan from the European Investment Bank (EIB) to support its expansion and modernization efforts as part of its “Health Sciences Campus 2.0” masterplan. The funding will be used to upgrade critical … Read the full press release

Orano Med awarded Biotech Prize for new cancer therapy development

(IN BRIEF) Orano Med, a subsidiary of Orano specialized in nuclear medicine, was awarded the Biotech Prize at the “Trophées de la HealthTech” event. The company is developing a new generation of targeted therapies for cancer using the unique properties … Read the full press release

EQT further invests in the healthcare sector with the acquisition of Integrated Clinical Oncology Network

EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction Icon Group is Australia’s largest vertically integrated cancer … Read the full press release

First non-melanoma skin cancer patients treated with the Rhenium-SCT® in Germany

The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau (PRESS RELEASE) HANAU, Germany, 4-Oct-2019 — /EuropaWire/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), … Read the full press release

OncoBeta® chosen as a 2019 Red Herring North America Top 100 Winner

New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. (PRESS RELEASE) Pasadena, CA, U.S.A., 5-Jul-2019 — /EuropaWire/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin … Read the full press release

Rhenium-SCT® (SCT= Skin Cancer Therapy) now being offered in Hanau, Germany

The interregional professional association for nuclear medicine in Hanau is the first treatment center in Germany offering Rhenium-SCT® for the treatment of non-melanoma skin cancer (PRESS RELEASE) GARCHING N. MUNICH, Germany, 13-May-2019 — /EuropaWire/ — OncoBeta® GmbH, a commercial stage … Read the full press release

First Non-Melanocytic Skin Cancer Patients treated with Rhenium-SCT® in South Africa

University of Pretoria Prof. Mike Sathekge is First in South Africa to Treat Non-Melanocytic Skin Cancer Patients with Rhenium-SCT® Garching n. Munich, Germany, 26-Nov-2018 — /EuropaWire/ — OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope … Read the full press release